Author:
Iwakuma T,Tochigi Y,Van Pelt C S,Caldwell L C,Terzian T,Parant J M,Chau G P,Koch J G,Eischen C M,Lozano G
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference34 articles.
1. Alt JR, Greiner TC, Cleveland JL, Eischen CM . (2003). Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis. EMBO J 22: 1442–1450.
2. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A et al. (1991). Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6: 1699–1703.
3. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC et al. (2004). A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119: 591–602.
4. Boyd MT, Vlatkovic N, Haines DS . (2000). A novel cellular protein (MTBP) binds to MDM2 and induces a G1 arrest that is suppressed by MDM2. J Biol Chem 275: 31883–31890.
5. Brady M, Vlatkovic N, Boyd MT . (2005). Regulation of p53 and MDM2 activity by MTBP. Mol Cell Biol 25: 545–553.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献